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Abstract Desmin ful¢ls important functions in maintenance of
muscle cells and mutations in the desmin gene have been linked
to a variety of myopathies. To ascertain the role of desmin’s
amino-terminal domain in muscle cells we generated embryonic
stem cells constitutively expressing desminv148 in a null back-
ground and investigated muscle cell development in vitro.
Desminv148 lacking the ¢rst 48 amino acid residues promotes
fusion of myoblasts, rescues myogenesis and down-regulates vi-
mentin expression in embryoid bodies, but hampers cardiomyo-
genesis and blocks smooth muscle development. These results
demonstrate that desmin’s amino-terminus has di¡erent roles
in skeletal, cardiac, and smooth muscle cell development and
function. $ 2002 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
Acquired and congenital cardiomyopathies and myopathies
are one of the major medical burdens. Reduced ventricular
function correlates with cardiomyocyte degeneration, cellular
atrophy and interstitial ¢brosis. Apart from myo¢bril degen-
eration, cytoskeletal rearrangements are the most prominent
primary and secondary events leading to end-stage heart dis-
eases and myopathies [1].
The cytoskeleton in cardiomyocytes, skeletal, and smooth
muscle cells is composed of the contractile apparatus, the sub-
membrane skeleton of the nucleus and plasma membrane,
including intercalated discs, costameres, and myotendinous
junctions, and three groups of ¢laments, the microtubules,
micro¢laments, and intermediate ¢laments (IFs) [2]. The latter
are composed of subunits expressed in a tissue-speci¢c fash-
ion, e.g. in muscle cells, desmin [3]. Desmin ¢laments provide
a transcytoplasmic integrating matrix to striated muscle cells
responsible for the alignment of sarcomeres [4], are essential
for maintenance of muscle structure and function [5], render
possible proper cellular force transmission [6], and perhaps
signal transduction. Defects in the desmin organisation have
been linked to a variety of cardiomyopathies and skeletal
muscle myopathies [7].
To ful¢l these functions in muscle tissue desmin interacts
with IF proteins, such as vimentin, paranemin, synemin, and
nestin [3,8], with a variety of IF-associated proteins, and with
components of the membrane skeleton, such as ankyrin to
which desmin speci¢cally binds via its amino-terminal head
domain [9]. This domain, rich in serine residues phosphory-
lated by Rho kinase, p21-activated PAK kinase, cdc2 kinase,
and protein kinases A and C [10], is a modulator of cell cycle-
and development-dependent stability and function of IFs. De-
letions within this domain altered the cellular organisation of
desmin IFs [11]. Here we hypothesise that the amino-terminal
domain of desmin ful¢ls speci¢c roles in muscle cells and
contributes to the interaction between cardiomyocytes and
myocytes, respectively.
To demonstrate the di¡erent functions of the amino-termi-
nal domain of desmin during embryonic muscle development
we replaced both wild type alleles of the desmin gene in em-
bryonic stem (ES) cells by the mutant allele desv 148.
Desminv148 lacking amino acid residues 1^48 of the head
domain is predominantly localised in the cytoplasm as dot-
like structures and rarely co-assembled with pre-existing IFs.
In desv 148=v 148 embryoid bodies (EBs) fusion of poly-
nucleated myotubes was partially restored; however, the
des3=3 smooth muscle phenotype could not be rescued. Car-
diogenesis was signi¢cantly inhibited and cell^cell interaction
and contraction was negatively a¡ected, demonstrating that
the amino-terminal domain of desmin has essential functions
in cardiomyocyte, skeletal and smooth muscle development
and maintenance of their phenotype.
2. Materials and methods
2.1. Vector construction and homologous recombination in ES cells
The replacement type vector contained a 6.5 kb EcoRI fragment of
the murine desmin gene [12], linked to the herpes simplex virus thy-
midine kinase (HSV-tk) gene. The neo cassette [13] was inserted in
3P to 5P orientation between two XhoI sites in exon 1 allowing tran-
scription of a mutated desmin message under the control of the tk
promoter of the neo cassette. Culture, electroporation, and selection
of AB2.1 ES cells on SNL76/7 ¢broblasts in medium M15, as well as
Southern blot, Northern blot, IF preparation, and Western blot anal-
ysis with monoclonal D3 anti-desmin antibodies (Hybridoma Bank,
Ames, IA, USA) have been described previously [12,14,15]. Two out
of 17 heterozygous cell lines were selected for gene conversion at the
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second allele resulting in seven homozygous cell lines with identical
phenotype. Mutant desmin was immunoprecipitated with polyclonal
desmin antibodies (Sigma #8281, 1:50) and detected with D3 anti-
bodies. PCR and RT-PCR were performed with desmin-speci¢c prim-
ers 5P-TGATGAGGCAGATGAGGGAG-3P and 5P-AACACCCT-
CTCTGTACCCTC-3P, Tm 60‡C, and a Py441 polyoma enhancer-
speci¢c primer 5P-GTAAGGTCCGGACCCACC-3P and desmin-spe-
ci¢c primer 5P-ATAGGATGGCGCTCGGGT-3P, Tm 49‡C, respec-
tively. Transfected SW13-IHF5 cells were selected for homologous
recombination at 150 Wg/ml G418. Chimeric mice were produced
from four ES cell lines.
2.2. In vitro di¡erentiation of ES cells and immuno£uorescence
microscopy
Each 400 ES cells were aggregated in 20 Wl drops in M15 for 4 days,
EBs were plated onto gelatinised (Difco) 10 cm tissue culture dishes
and cardiomyogenesis, skeletal and smooth muscle development was
monitored and analysed essentially as in [15].
Cells and EBs on gelatinised coverslips were washed with phos-
phate-bu¡ered saline, ¢xed in 96% ethanol at 320‡C for 20 min,
stained for desmin with D3 and K5-pDes (Dr Gert Schaart, Univer-
siteit Maastricht, The Netherlands, 1:25), connexin 43 (Sigma C6219,
1:400), vimentin (ICN 647401, 1:100), myosin MF20 (Hybridoma
Bank), smooth muscle actin (Sigma #2547) or myogenin F5D anti-
bodies (Dr Woody Wright, Pasteur Institute, Paris, France) for
90 min, and consecutively with FITC- and TRITC-conjugated second-
ary antibodies (Sigma F4018, 1:200; T7028, 1:200; T-5268, 1:80) for
90 min. Photomicrographs were taken on a Leica TCS SP confocal
microscope.
3. Results
3.1. Expression of desminv 148 in des3=3 ES cells and
embryoid bodies
ES cells expressing a mutated desmin protein lacking the
amino-terminal membrane skeleton-binding domain in a des-
min null background were generated by homologous recom-
bination at the desmin locus. A replacement type vector with
the MC1neo cassette inversely inserted in front of the methio-
nine 49 codon in exon 1 of the murine desmin gene was used
to generate the desv 148 allele (Fig. 1A^C). Spontaneous gene
conversion resulted in seven desv 148=v 148 cell lines. Correct
homologous recombination was veri¢ed with probes as indi-
cated in Fig. 1 (Fig. 2A, and data not shown).
Constitutive transcription of a 2.6 kb mRNA in ES cells
was exclusively driven by the weak tk promoter of the
MC1neo cassette (Figs. 1D and 2B). RT-PCR with primers
binding to the Py441 polyoma enhancer of the MC1neo cas-
sette and the very 3P part of exon 1, and situated within exon
4 and the 3P untranslated region, respectively, demonstrated
that mutated exons 1^9 were correctly and constitutively tran-
scribed (Fig. 2C). Translation of desminv148 starting at the
bona ¢de start codon methionine 49 was veri¢ed by immuno-
precipitation of ES cell lysates, and SDS^PAGE demonstrated
a Mr of 48 800 close to the theoretical Mr of 48 386 (Fig.
Fig. 1. Homologous recombination at the desmin locus replacing the
wild type allele by desv 148. A: Restriction map of the murine des-
min locus. B: Targeting vector. C: Mutant desv 148 allele. Shaded
boxes, exons; white boxes, cloning vector; Tk, HSV thymidine ki-
nase gene; Neo, neomycin gene; arrows, orientation of tk pro-
moters; bars, restriction fragments and probes used for identi¢ca-
tion of the mutant allele; R, EcoRI; H, HindIII; X, XhoI.
D: mRNA transcribed from the desv 148 allele. Note that the tk
promoter in the neo cassette also drives transcription in the 5P-3Por-
ientation of the locus (long arrow). The sequence shows the unique
start codon at bp 228 in exon 1. Lower-case letters, tk promoter;
upper-case letters, exon 1 of the desmin gene.
Fig. 2. Identi¢cation of the desv 148 allele and desminv148 protein
in ES cells and EBs. A: Southern blot analysis of EcoRI-digested
genomic DNA from desþ=þ, desþ=v 148, and desv 148=v 148 ES cell
lines, hybridisation with probe A (see Fig. 1). B: Northern blot
analysis of desþ=þ, desþ=v 148, and desv 148=v 148 undi¡erentiated
ES cell lines, hybridisation with probe D (see Fig. 1). C2C12, posi-
tive control. C: RT-PCR with RNA from undi¡erentiated ES cells
with primers amplifying the Py441 polyoma enhancer containing
mutant exon 1 (Py-E1) fragment and exon 4 to exon 9, respectively.
GAPDH, loading control. D: Western blot analysis of immunopre-
cipitated ES cell lysates. Heart, positive control. E: Northern blot
analysis of RNA from developing EBs. F,G: Western blot analysis
of IF preparations from 10 day old EBs (F) and from high resolu-
tion SDS^PAGE of desmin and desminv148 (G).
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2D,G). In desv 148=v 148 EBs desv 148 mRNA was transcribed
throughout the period of in vitro development (Fig. 2E).
Desminv148 could be enriched in IF preparations of EBs
(Fig. 2F), thus demonstrating that desminv148 partially co-
assembles with and perhaps in£uences other IFs.
Desminv148 was identi¢ed in undi¡erentiated desv 148=v 148
ES cells as a weak and di¡use cytoplasmic staining (data not
shown), and in all cells of desv 148=v 148 EBs (Fig. 3), whereas
in wild type EBs only muscle cells expressed desmin [15].
Ectopically expressed desminv148 was partially integrated in
vimentin ¢laments, however, a signi¢cant part localised in the
cytoplasm and perinuclear aggregates (Fig. 3F). In SW13-
IHF5 adenocarcinoma cells lacking all IF proteins des-
minv148 could not form de novo IFs, and caused cataract
formation in the eye lens of chimeric mice (data not shown).
3.2. Expression of desminv 148 in a null background
di¡erentially a¡ects heart, skeletal and smooth muscle
development and vimentin expression in EBs
Development and function of desv 148=v 148 cardiomyo-
cytes were severely compromised (Fig. 4A), whereas in
desþ=v 148 and des3=3EBs [15] no negative e¡ect was ob-
served. Rhythmic beating was decreased to 34R 11 min31,
n=62 (wild type: 91R 40 min31, n=84), the number of beat-
ing foci per EB was reduced to 2.2R 1.1 (wild type: 4.3 R 1.3)
and the majority of foci was signi¢cantly smaller than in wild
type EBs.
Skeletal muscle formation in EBs is initiated by fusion of
presumptive myoblasts to small oligonucleated myotubes, fol-
lowed by fusion to polynucleated contracting myotubes which
¢nally form large arrays of well developed beating myotubes
[15]. Constitutive expression of desminv148 promoted devel-
opment and/or fusion of presumptive myoblasts in a dose-
dependent manner (Fig. 4B). Development of polynucleated
contracting myotubes was partially rescued by desminv148
(Fig. 4C). Myotubes expressed myosin (Fig. 4D) and myoge-
nin (Fig. 4E), which was absent in des3=3 myotubes [15],
however, never formed large arrays over extended periods of
time. Thus desminv148 facilitates myogenic di¡erentiation,
e¡ectively drives cells into fusion, but fails to sustain the adult
skeletal muscle phenotype.
Development of contracting smooth muscle cells was sig-
ni¢cantly reduced in desþ=v 148, and essentially absent in
desv 148=v 148 EBs (Fig. 4F). The number of smooth muscle
actin-positive ¢broblasts was reduced (data not shown). These
results suggest that desminv148 cannot support the multistep
transition process in which non-muscle cells are converted to
myo¢broblasts and to smooth muscle cells.
Vimentin expression continuously increased in wild type
EBs and was up-regulated in des3=3 EBs shortly after the
time when desmin is expressed at the onset of cardiogenesis
and myogenesis in wild type EBs (Figs. 2E and 4G). In
desv 148=v 148 EBs increase in vimentin expression stopped
at the time when cardiomyocytes and myoblasts started to
develop (Fig. 4G). These results demonstrate that desminv148
in£uences vimentin expression and suggest that vimentin may
step in for desmin in des3=3 EBs but not in EBs with func-
tionally compromised desmin.
4. Discussion
A common feature of IF proteins is that their amino-termi-
nal domain interacts with a variety of cellular targets and
contributes to their tissue-speci¢c function [3,16]. Knock-out
of the desmin gene demonstrated its signi¢cant roles in car-
diac, skeletal and smooth muscle function [5,17,18]. Here we
reported that desminv148 lacking 48 amino acids of the ami-
no-terminal head domain a¡ects cardiac, skeletal and smooth
muscle to di¡erent degrees in EBs thus demonstrating that
desmin exerts di¡erent roles via its head domain during
muscle development.
Stable but low expression of desminv148 in a null back-
ground in ES cells and EBs was achieved by introduction of
a reverted HSV-tk promoter in front of the methionine 49
codon in exon 1 of both alleles of the murine desmin gene.
High level expression of desmin or mutated desmin was toxic
to ES cells (Puz and Weitzer, unpublished results). Constitu-
tive transcription of a single, correctly spliced mRNA, exclud-
Fig. 3. Immunolocalisation of desmin, desminv148 and vimentin in
EBs, at day 13. Myoblasts and ¢broblasts in wild type (A,C,E,G)
and desv 148=v 148 EBs (B,D,F,H). A,B,E,F: Antibody to desmin.
C,D,G,H: Antibody to vimentin. Magni¢cation: (A^D) 400U,
(E^H) 800U.
FEBS 26285 5-7-02
A. Ho«llrigl et al./FEBS Letters 523 (2002) 229^233 231
ing dicistronic expression, gave rise to translation of
desminv148. Desminv148 could not form de novo ¢laments
or aggregates in ES or SW13-IHF5 cells, partially integrated
in pre-existing IFs in di¡erentiated cell types and was also
found as perinuclear aggregates as observed in several des-
min-related cardiomyopathies [7]. Desminv148 had no ob-
vious in£uence on any other cell type than muscle cells be-
cause development of extra-embryonic endoderm, neurones
and erythrocytes was not a¡ected in desv 148=v 148 EBs. Ec-
topic expression of desminv148 was demonstrated in eye
lenses of chimeric mice, however, germline transmission of
the desv 148 allele was never possible due to severe malforma-
tion of male and female reproductive organs, phenotypically
resembling hermaphrodites. All mice with more than 30% of
the coat coloured died within weeks suggesting that
desminv148 expression was lethal.
In EBs desminv148 di¡erentially in£uenced the develop-
ment of cardiac, skeletal and smooth muscle cells. In
desþ=v 148 EBs cardiomyocytes were not a¡ected, smooth
muscle cells were negatively a¡ected, and fusion of myoblasts
was promoted. In desv 148=v 148 EBs cardiomyogenesis was
severely hampered. Reduced numbers of cardiomyocytes per
beating focus and signi¢cantly reduced beating rates, which
were not observed in des3=3 EBs [15], and reduced expression
of connexin 43 in desv 148=v 148 cardiomyocytes (data not
shown) suggest that headless desmin actively interferes with
either cell^cell recognition, attachment or signal transduction
between cardiomyocytes.
Smooth muscle cells were essentially absent in desminv148
EBs and the number of myo¢broblasts, supposed to be inter-
mediates in smooth muscle development, was reduced. These
results correlate with the requirement of desmin in small ar-
tery smooth muscle cells [18], and indirectly suggest an im-
portant function of desmin’s head domain in smooth muscle
development; however, the mechanism remains elusive.
Fusion of presumptive skeletal muscle myoblasts was sig-
ni¢cantly increased, thus desminv148 rescued the des3=3 phe-
notype [15] either by increasing the number of early myoblasts
and/or by promoting fusion of non-myogenic cells. The dis-
crepancy between the in vitro (this study and [15]) and in vivo
data [19] may well arise from di¡erent environmental in£uen-
ces in EBs and somites, respectively. Absence of extracellular
matrix or paracrine signals may cause indispensability of des-
min in EBs. Timely onset of fusion demonstrates that in vitro
desmin is an essential, but not the committing factor in myo-
blasts, and that non-¢lamentous desminv148 is su⁄cient for
cell fusion. However, the absence of large long-living myo-
tubes in desv 148=v 148 EBs suggests that desmin’s head do-
main is indispensable for maintenance of the skeletal muscle
phenotype. Down-regulation of vimentin expression by des-
minv148 may in addition be responsible for the reduced lon-
gevity of both skeletal muscle cells and cardiomyocytes. On
Fig. 4. In£uence of desminv148 on cardiomyogenesis, skeletal and smooth muscle myogenesis in a des3=3 background. A: Development of
beating cardiomyocytes in desþ=þ (b, +/+), desþ=v 148 (E, +/v), and desv 148=v 148 (8, v/v) EBs. Number of cell lines and EBs checked:
desþ=þ, 2/5990; desþ=v 148, 5/3045; desv 148=v 148, 4/6806. B,C: Percentage EBs with fusing cells (B) and contracting myotubes (C). desþ=3,
(+/3) ; des3=3, (3/3). Mean values were calculated from maxima R2 days; desþ=þ, 2/3471; desþ=3, 5/4502; desþ=v 148, 5/3694; des3=3, 7/3665;
desv 148=v 148, 4/4244. D,E: Myosin (D) and myogenin immunolocalisation (E) in desv 148=v 148 myotubes. Magni¢cation 400U. F: Percentage
EBs with contracting smooth muscle cells. desþ=þ, 2/1004; desþ=3, 5/4502; desþ=v 148, 5/3694; desv 148=v 148, 4/6501. G: Expression of vimentin
mRNA in EBs. Each 20 Wg mRNA from desþ=þ (b), desv 148=v 148 (8), and des3=3 (F) EBs were analysed by semi-quantitative Northern
blotting.
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the other hand, up-regulation of vimentin in des3=3 EBs
might sustain cardiomyogenesis but not skeletal muscle devel-
opment, because vimentin cannot drive fusion. Here we dem-
onstrated for the ¢rst time that desmin and vimentin expres-
sion is linked by a feedback loop, thus providing evidence for
the hypothesis that desmin might be directly or indirectly, via
diverting di¡erentiation, involved in signal transduction mod-
ulating the expression of other IF proteins.
Desmin is not necessary for embryogenesis [19,20] ; how-
ever, absence of desmin causes severe defects in all muscle
tissues resembling the pathology of myopathies and cardio-
myopathies in the adult [5,17,18]. Additionally, mutant desmin
alleles have been linked to various cardiomyopathies [1] and
here we suggest that mutations or deletions within the amino-
terminal domain of desmin may also contribute to cardiomyo-
pathies. Finally, these in vitro experiments made it possible to
assess the di¡erential in£uence of desminv148 on heart, skel-
etal and smooth muscle cell development which was not pos-
sible in vivo, due to lack of germline transmission of the
desv 148 allele.
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